Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1008 of 1,261
  1. US 7683066

    Isoquinolines useful as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted
  2. US 7683080

    Stable iansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted
  3. US 7683065

    Pyridines useful as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted
  4. US 7683188

    Process for preparation of mycophenolic acid and ester derivatives thereof

    TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted
  5. US 7683177

    Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted
  6. US 7683095

    Compositions and methods of treating, reducing and preventing cardiovascular diseases and disorders with polymethoxyflavones

    The United States of America, as represented by the Secretary of Agriculture · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted
  7. US 7683083

    Biphenyl derivatives as modulators of voltage gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted
  8. WO 2010030203

    ANTICORPS MONOCLONAL DIRIGÉ CONTRE LA TRANSTHYRÉTINE HUMAINE AMYLOÏDOGÈNE ET DES FORMES MODIFIÉES DE CELLE-CI ET SON UTILISATION DANS LA DÉTECTION ET LE TRAITEMENT DE LA FAP ET DE PATHOLOGIES PRÉSENTANT UNE TTR MODIFIÉE

    BIOCODEX INCUBACAO DE EMPRESAS [PT] · Granted Mar 18, 2010 · Expires Mar 13, 2030

    granted
  9. US 7678813

    Azadecalin Glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Mar 16, 2010 · Expires Mar 11, 2030

    granted
  10. US 7678938

    Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 16, 2010 · Expires Mar 11, 2030

    granted
  11. US 7678552

    Method for selecting therapeutic agents for cancer treatment

    Precision Therapeutics, Inc. · Granted Mar 16, 2010 · Expires Mar 11, 2030

    granted
  12. US 7678824

    Methods for treatment with bucindolol based on genetic targeting

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 16, 2010 · Expires Mar 11, 2030

    granted
  13. US 7678922

    Processes for the preparation of 1,2,4-oxadiazole benzoic acids

    PTC THERAPEUTICS, INC. · Granted Mar 16, 2010 · Expires Mar 11, 2030

    granted
  14. US 7678890

    Compositions and methods of treating disease with FGFR fusion proteins

    Five Prime Therapeutics, Inc. · Granted Mar 16, 2010 · Expires Mar 11, 2030

    granted
  15. US 7678828

    Methods for the formulation and manufacture of artesunic acid for injection

    The United States of America as represented by the Secretary of the Army · Granted Mar 16, 2010 · Expires Mar 11, 2030

    granted
  16. US 7678918

    Intermediates for imidazonaphthyridines

    Graceway Pharmaceuticals. LLC · Granted Mar 16, 2010 · Expires Mar 11, 2030

    granted
  17. US 7678816

    Method of stabilizing lansoprazole

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 16, 2010 · Expires Mar 11, 2030

    granted
  18. US 7678764

    Protein formulations for use at elevated temperatures

    JOHNSON & JOHNSON REGENERATIVE THERAPEUTICS, LLC · Granted Mar 16, 2010 · Expires Mar 11, 2030

    granted
  19. US 7678799

    Crystalline ziprasidone HCl and processes for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 16, 2010 · Expires Mar 11, 2030

    granted
  20. US 7678802

    Quinazolines useful as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Mar 16, 2010 · Expires Mar 11, 2030

    granted
  21. US 7678569

    Cloned genome of infectious hepatitis C virus strain HC-TN and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 16, 2010 · Expires Mar 11, 2030

    granted
  22. US 7678387

    Drug delivery systems

    Capricorn Pharma Inc. · Granted Mar 16, 2010 · Expires Mar 11, 2030

    granted
  23. US 7678386

    Liposomes coated with selected antibodies that bind to aminophospholipids

    The Board of Regents of the University of Texas · Granted Mar 16, 2010 · Expires Mar 11, 2030

    granted
  24. US 7674778

    Oligonucleotides comprising a conjugate group linked through a C5-modified pyrimidine

    Alnylam Pharmaceuticals, Inc. · Granted Mar 9, 2010 · Expires Mar 4, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.